AI Platform Revolutionizes Health Technology Development Vamstar, a London-based AI company, has secured £900k funding from Innovate UK’s Sovereign AI programme. This will support a UK-owned AI platform aiding health technology developers in anticipating payer requirements and predicting launch outcomes before trial protocols are finalized. Global pharmaceutical R&D spending exceeds £200 billion…
No responses yet